Evidence map›Paper›PMID 19844637›Full record

ReviewNatural product reports2009

Genomic basis for natural product biosynthetic diversity in the actinomycetes.

Markus Nett, Haruo Ikeda, Bradley S Moore

Abstract readReview
In one paragraph

Review in Natural product reports, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 379 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
379citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

379 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. NewTheScientificWorldJournal · 2025
    Pooled it
  2. Article
  3. Pangenome ofEcology and evolution · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Comparative genome analysis and secondary biosynthetic potential of the Streptomyces microflavus strains isolated from high altitude.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  10. Article
  11. Multicomponent Reactions for the Synthesis of Oxazepines.Topics in current chemistry (Cham) · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Pathogens (Basel, Switzerland) · 2026
    Article
  16. Leveraging antibiotic hormesis for cryptic natural product discovery.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  17. Review
  18. Article
  19. Article
  20. Article

319 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Markus NettLeibniz Institute for Natural Product Research and Infection Biology - Hans-Knöll Institute, Beutenbergstr. 11a, 07745, Jena, Germany. markus.nett@hki-jena.de
Haruo Ikeda
Bradley S Moore

Funding

Natural Product Genome MiningR01GM085770 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JENSEN, PAUL R, MOORE, BRADLEY S · 2009 to 2024
$5.8M
Salinosporamide Biosynthesis and EngineeringR01CA127622 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MOORE, BRADLEY S · 2007 to 2016
$2.8M
NCI NIH HHS CA127622NCI NIH HHS R01 CA127622NIGMS NIH HHS GM085770NIGMS NIH HHS R01 GM085770
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biological ProductsGenomeActinobacteriaBiological Products

Identifiers

PMID19844637
PMCPMC3063060

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.